Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, Perol M, Merle P, Sibille A, Markman B, Bouchaab H, Moskovitz M, Schumann C, Gregorc V, Klein AB, Perez ID, Sawyer W, Licour M, Christoph D (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: ELSEVIER
City/Town: AMSTERDAM
Pages Range: S805-S806
Conference Proceedings Title: ANNALS OF ONCOLOGY
DOI: 10.1016/j.annonc.2020.08.115
Authors with CRIS profile
Involved external institutions
Fondazione IRCCS: Istituto Nazionale dei Tumori
Italy (IT)
Institut Curie
France (FR)
AstraZeneca UK Limited
United Kingdom (GB)
The University of Liverpool
United Kingdom (GB)
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
Switzerland (CH)
Centre Léon-Bérard (UNICANCER)
France (FR)
Kliniken Essen-Mitte
Germany (DE)
Rambam Health Care Campus
Israel (IL)
Centre Hospitalier Universitaire de Liège (CHU Liège)
Belgium (BE)
Rijnstate Ziekenhuis
Netherlands (NL)
Ospedale San Raffaele (früher: Centro San Raffaele del Monte Tabor Foundation)
Italy (IT)
Cabrini Hospital
Australia (AU)
CHU Clermont-Ferrand
France (FR)
Universidad de Alcalá (UAH)
Spain (ES)
Klinikverbund Allgäu
Germany (DE)
Italy (IT)
Institut Curie
France (FR)
AstraZeneca UK Limited
United Kingdom (GB)
The University of Liverpool
United Kingdom (GB)
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
Switzerland (CH)
Centre Léon-Bérard (UNICANCER)
France (FR)
Kliniken Essen-Mitte
Germany (DE)
Rambam Health Care Campus
Israel (IL)
Centre Hospitalier Universitaire de Liège (CHU Liège)
Belgium (BE)
Rijnstate Ziekenhuis
Netherlands (NL)
Ospedale San Raffaele (früher: Centro San Raffaele del Monte Tabor Foundation)
Italy (IT)
Cabrini Hospital
Australia (AU)
CHU Clermont-Ferrand
France (FR)
Universidad de Alcalá (UAH)
Spain (ES)
Klinikverbund Allgäu
Germany (DE)
How to cite
APA:
Girard, N., Fietkau, R., Garassino, M., Garrido, P., Field, J.K., Peters, S.,... Christoph, D. (2020). Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. In ANNALS OF ONCOLOGY (pp. S805-S806). AMSTERDAM: ELSEVIER.
MLA:
Girard, N., et al. "Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy." Proceedings of the ESMO Virtual Congress AMSTERDAM: ELSEVIER, 2020. S805-S806.
BibTeX: Download